Key facts
- President Donald Trump announced Wednesday the selection of Dr. Heidi Overton to lead the Food and Drug Administration.
- Overton is a medical doctor and deputy director of the White House Domestic Policy Council.
- She has championed Trump's health initiatives, including drug pricing deals and a vaccine order.
- Overton's nomination faces scrutiny over her stance on abortion pills and potential rollback of FDA rules.
- The previous FDA head, Dr. Marty Makary, resigned in May, leaving unfinished projects.
- Overton's confirmation requires Senate approval and will involve questions from the Senate Health, Education, Labor and Pensions Committee.
President Donald Trump announced Wednesday that Dr. Heidi Overton, a top White House aide, has been chosen to lead the Food and Drug Administration.
Overton, a medical doctor and deputy director of the White House Domestic Policy Council, has been a key figure in advancing Trump’s health agenda, including initiatives aimed at lowering drug prices and a controversial vaccine order. She previously served as chief policy officer at the conservative America First Policy Institute.
If confirmed by the Senate, Overton would face a complex landscape of competing priorities, including Trump’s specific health goals, traditional Republican anti-regulatory interests, and the agenda of Health Secretary Robert F. Kennedy Jr. Her nomination has drawn criticism from Democratic senators, who have labeled her an "anti-abortion extremist."
The previous FDA head, Dr. Marty Makary, resigned in May, leaving behind unfinished work on issues such as ultraprocessed foods, antidepressants, and COVID-19 vaccines. Makary also faced industry pressure regarding flavored e-cigarettes and decisions on biotech drugs.
Overton's confirmation process will involve scrutiny from the Senate Health, Education, Labor and Pensions Committee, chaired by Republican Sen. Bill Cassidy. Key issues expected to be raised include her stance on abortion pills and her role in promoting vaccine skepticism.